In Vitro Activity and Resistance Profile of Samatasvir, a Novel NS5A Replication Inhibitor of Hepatitis C Virus
BILELLO, J. P, LALLOS, L. B, MCCARVILLE, J. F, LA COLLA, M, SERRA, I, CHAPRON, C, GILLUM, J. M, PIERRA, C, STANDRING, D. N, SEIFER, M
Published in Antimicrobial agents and chemotherapy (01.08.2014)
Published in Antimicrobial agents and chemotherapy (01.08.2014)
Get full text
Journal Article
A Role for Saccharomyces cerevisiae Cul8 Ubiquitin Ligase in Proper Anaphase Progression
Michel, Jennifer J, McCarville, Joseph F, Xiong, Yue
Published in The Journal of biological chemistry (20.06.2003)
Published in The Journal of biological chemistry (20.06.2003)
Get full text
Journal Article
The prevalence of HCV NS5A, nucleoside and protease inhibitor resistance associated variants and the effects on treatment with ledipasvir sofosbuvir + or - RBV in the Phase 3 ION studies
Dvory-Sobol, H, Doehle, B, Svarovskaia, E, McCarville, J F, Pang, P, Afdhal, N, Kowdley, K V, McHutchison, J, Miller, M, Mo, H
Published in Antiviral therapy (01.01.2014)
Get full text
Published in Antiviral therapy (01.01.2014)
Journal Article
Persistence of resistance-associated variants in hepatitis C virus (HCV) genotype 1-4 infected subjects following 3-day samatasvir monotherapy
Heinrich, B, Vince, B, Hill, J M, Lawitz, E J, O'Riordan, W, Webster, L R, Gruener, D M, Mofsen, R S, Murillo, A, McCarville, J F, Pietropaolo, K, Bilello, J P, Sweeney, L, Seifer, M, Mayers, D
Published in Antiviral therapy (01.01.2014)
Get full text
Published in Antiviral therapy (01.01.2014)
Journal Article